Previous 10 | Next 10 |
Shares of Insmed Incorporated (NASDAQ: INSM) traded at a new 52-week high today and are currently trading at $63.92. So far today, approximately 661.25k shares have been exchanged, as compared to an average 30-day volume of 5.3M shares. Insmed Incorporated, a biopharmaceutical company, develo...
2024-06-12 14:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-05 09:00:13 ET Stephen Willey from Stifel Nicolaus issued a price target of $74.00 for INSM on 2024-06-05 07:25:00. The adjusted price target was set to $74.00. At the time of the announcement, INSM was trading at $57. The overall price target consensus is at $59...
Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference PR Newswire BRIDGEWATER, N.J. , June 5, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with...
Insmed to Host Commercial Webinar on June 4, 2024 PR Newswire BRIDGEWATER, N.J. , May 30, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare disease...
2024-05-30 14:50:45 ET More on Insmed Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade) Insmed, Inc. (INSM) Q1 2024 Earnings Call Transcript Insmed intends to raise $500M via equity offering Insmed surges on late-stage win for lung disease ...
Insmed Announces Pricing of $650 Million Public Offering of Common Stock PR Newswire BRIDGEWATER, N.J. , May 30, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serio...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 37.2% to $0.0494 on volume of 615,002,672 shares Innovative Eyewear Inc. (LUCY) rose 131.5% to $0.949 on volume of 566,381,896 shares Faraday Future Intelligent Electric Inc. (FFIE) fell...
2024-05-29 05:28:26 ET More on Insmed Insmed Strikes Gold With Phase 3 Bronchiectasis Win (Rating Upgrade) Insmed surges on late-stage win for lung disease therapy (update) Seeking Alpha’s Quant Rating on Insmed Historical earnings data for Insmed ...
2024-05-28 21:15:02 ET Barclays analyst issues OVERWEIGHT recommendation for INSM on May 28, 2024 07:54PM ET. The previous analyst recommendation was Overweight. INSM was trading at $48.06 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
News, Short Squeeze, Breakout and More Instantly...
2024-07-12 10:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-09 08:00:06 ET Vamil Divan from Guggenheim issued a price target of $95.00 for INSM on 2024-07-09 06:44:00. The adjusted price target was set to $95.00. At the time of the announcement, INSM was trading at $70.05. The overall price target consensus is at $72.91 w...
Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis Conference PR Newswire —New Graph Depicting 52-Week FEV1 Data Illustrate Significantly Less Decline in Lung Function for Bren...